Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.

  title={Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.},
  author={Massimo Martino and Mauro Montanari and Benedetto Bruno and Giuseppe Console and Giuseppe Irrera and Giuseppe Messina and Massimo Offidani and Ilaria Scortechini and Tiziana Moscato and Roberta Fedele and Giuseppe Milone and Luca Castagna and Attilio Olivieri},
  journal={Expert opinion on biological therapy},
  volume={12 11},
INTRODUCTION There are considerable concerns regarding the appropriate use of health care resources to reduce costs and waiting lists associated with autologous hematopoietic progenitor cell transplantation (AHPCT). One of the strategies to reach this goal is outpatient-based (OpB) AHPCT. AREAS COVERED We reviewed all the reported experiences in this field and illustrated the various models of OpB AHPCT. EXPERT OPINION The role of high-dose melphalan (HDM) followed by AHPCT in the treatment… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
4 Citations
104 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 104 references

Feasibility of outpatient autologous stem cell transplantation in 238 patients with haematologic malignancy

  • M Montanari, I Scortechini, D Capelli
  • Bone Marrow Transplant
  • 2011
Highly Influential
4 Excerpts

A phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection

  • GL IIPhillips, SH Bernstein, JL Liesveld
  • Biol Blood Marrow Transplant
  • 2011
1 Excerpt

At-home management of aplastic phase following high-dose melphalan and autologous haematopoietic stem cell transplantation for multiple myeloma patients: a pilot study. ASH Annual Meeting Abstracts

  • M Martino, G Pellicano, T Moscato
  • Blood
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…